The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

S Bidlingmaier, X Zhu, B Liu - Journal of molecular medicine, 2008 - Springer
Abstract Human CD133 (human prominin-1), a five transmembrane domain glycoprotein,
was originally identified as a cell surface antigen present on CD34+ hematopoietic stem …
被引用次数：345 相关文章

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.

S Bidlingmaier, X Zhu, B Liu - Journal of Molecular Medicine, 2008 - search.ebscohost.com
Abstract Human CD133 (human prominin-1), a five transmembrane domain glycoprotein,
was originally identified as a cell surface antigen present on CD34+ hematopoietic stem …

[引用][C] The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

S BIDLINGMAIER, X ZHU… - Journal of molecular …, 2008 - pascal-francis.inist.fr
The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

S Bidlingmaier, X Zhu, B Liu - Journal of molecular …, 2008 - pubmed.ncbi.nlm.nih.gov
Human CD133 (human prominin-1), a five transmembrane domain glycoprotein, was
originally identified as a cell surface antigen present on CD34+ hematopoietic stem cells …

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.

S Bidlingmaier, X Zhu, B Liu - Journal of Molecular Medicine (Berlin …, 2008 - europepmc.org
Abstract Human CD133 (human prominin-1), a five transmembrane domain glycoprotein,
was originally identified as a cell surface antigen present on CD34+ hematopoietic stem …

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

S Bidlingmaier, X Zhu, B Liu - Journal of Molecular Medicine, 2008 - search.proquest.com
Abstract Human CD133 (human prominin-1), a five transmembrane domain glycoprotein,
was originally identified as a cell surface antigen present on CD34+ hematopoietic stem …

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

S Bidlingmaier, X Zhu, B Liu - Journal of Molecular Medicine, 2008 - infona.pl
Human CD133 (human prominin-1), a five transmembrane domain glycoprotein, was
originally identified as a cell surface antigen present on CD34+ hematopoietic stem cells …
[HTML] nih.gov

[HTML][HTML] The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

S Bidlingmaier, X Zhu, B Liu - Journal of molecular medicine …, 2008 - ncbi.nlm.nih.gov
Abstract Human CD133 (human prominin-1), a five transmembrane domain glycoprotein,
was originally identified as a cell surface antigen present on CD34+ hematopoietic stem …

[引用][C] The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

S BIDLINGMAIER - J Mol Med, 2008 - cir.nii.ac.jp

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.

S Bidlingmaier, X Zhu, B Liu - Journal of Molecular Medicine (Berlin …, 2008 - europepmc.org
Abstract Human CD133 (human prominin-1), a five transmembrane domain glycoprotein,
was originally identified as a cell surface antigen present on CD34+ hematopoietic stem …